Association between the insulin resistance and all-cause mortality in patients with moderate and severe aortic stenosis: a retrospective cohort study

被引:7
作者
Huang, Rihua [1 ,2 ]
Xu, Xinghao [1 ,2 ]
Xu, Chaoguang [1 ,2 ]
Zhang, Shaozhao [1 ,2 ]
Xiong, Zhenyu [1 ,2 ]
Liu, Menghui [1 ,2 ]
Huang, Yiquan [1 ,2 ]
Wen, Han [1 ,2 ]
Guo, Yue [1 ,2 ]
Liao, Xinxue [1 ,2 ]
Zhuang, Xiaodong [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, 58 Zhongshan 2nd Rd, Guangzhou 510080, Peoples R China
[2] Sun Yat Sen Univ, NHC Key Lab Assisted Circulat, Guangzhou, Peoples R China
关键词
Triglyceride-glucose index; Mortality; Aortic stenosis; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; CARDIOVASCULAR MORTALITY; METABOLIC SYNDROME; VALVE STENOSIS; RECOMMENDATIONS; DISEASE; UPDATE; ECHOCARDIOGRAPHY; PROGRESSION;
D O I
10.1186/s12933-023-01975-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe triglyceride-glucose (TyG) index is a reliable surrogate marker of insulin resistance (IR). However, whether the TyG index has prognostic value in patients with moderate to severe aortic stenosis (AS) remains unclear.MethodsThis study enrolled 317 patients with moderate to severe AS at the First Affiliated Hospital of Sun Yat-Sen University. The patients were grouped according to the cut-off value of the TyG index. Cox regression with Firth's penalized maximum likelihood method and restricted cubic splines regression were conducted to assess the association between the TyG index and all-cause mortality. The added value of the TyG index included in the traditional risk factors model for outcome prediction was also analyzed.ResultsAmong 317 patients (mean age 67.70 years, 62.8% male), there was 84 all-cause mortality during a median 38.07 months follow-up. After fully adjusting for confounders, a per-unit increase in the TyG index was associated with a 62% higher all-cause mortality risk (HR 1.622, 95% CI 1.086-2.416, p = 0.018). The restricted cubic splines regression model revealed a linear association between the TyG index and the risk of all-cause mortality (p for nonlinearity = 0.632). The addition of the TyG index in the basic risk model has an incremental effect on the prediction of mortality [C-statistic change from 0.755 to 0.768; continuous net reclassification improvement (95% CI): 0.299 (0.051-0.546), p = 0.017; integrated discrimination improvement: 0.017 (0.001-0.033), p = 0.044].ConclusionsHigher IR assessed by the TyG index was associated with a higher risk of all-cause mortality in patients with moderate and severe AS.
引用
收藏
页数:10
相关论文
共 37 条
  • [1] Use of the triglyceride-glucose index (TyG) in cardiovascular disease patients
    Alizargar, Javad
    Bai, Chyi-Huey
    Hsieh, Nan-Chen
    Wu, Shu-Fang Vivienne
    [J]. CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [2] GLP-1 receptor agonists and cardiovascular outcome trials: An update
    Andrikou, Eirini
    Tsioufis, Costas
    Andrikou, Ioannis
    Leontsinis, Ioannis
    Tousoulis, Dimitrios
    Papanas, Nikolaos
    [J]. HELLENIC JOURNAL OF CARDIOLOGY, 2019, 60 (06) : 347 - 351
  • [3] Baumgartner H, 2017, J AM SOC ECHOCARDIOG, V30, P372, DOI [10.1016/j.echo.2017.02.009, 10.1093/ehjci/jew335]
  • [4] Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis
    Briand, Martin
    Lemieux, Isabelle
    Dumesnil, Jean G.
    Mathieu, Patrick
    Cartier, Amelie
    Despres, Jean-Pierre
    Arsenault, Marie
    Couet, Jacques
    Pibarot, Philippe
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (11) : 2229 - 2236
  • [5] Cai XY, 2020, BMJ-BRIT MED J, V370, DOI [10.1136/bmi.m2297, 10.1136/bmj.m2297]
  • [6] Global epidemiology of valvular heart disease
    Coffey, Sean
    Roberts-Thomson, Ross
    Brown, Alex
    Carapetis, Jonathan
    Chen, Mao
    Enriquez-Sarano, Maurice
    Zuhlke, Liesl
    Prendergast, Bernard D.
    [J]. NATURE REVIEWS CARDIOLOGY, 2021, 18 (12) : 853 - 864
  • [7] Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis
    Coisne, Augustin
    Montaigne, David
    Ninni, Sandro
    Lamblin, Nicolas
    Lemesle, Gilles
    Delsart, Pascal
    Filiot, Alexandre
    Andrey, Paul
    Balaye, Pierre
    Butruille, Laura
    Decoin, Raphael
    Woitrain, Eloise
    Granada, Juan F.
    Staels, Bart
    Bauters, Christophe
    [J]. HEART, 2022, 108 (22) : 1815 - 1821
  • [8] Association of Cardiometabolic Multimorbidity With Mortality The Emerging Risk Factors Collaboration
    Di Angelantonio, Emanuele
    Kaptoge, Stephen
    Wormser, David
    Willeit, Peter
    Butterworth, Adam S.
    Bansal, Narinder
    O'Keeffe, Linda M.
    Gao, Pei
    Wood, Angela M.
    Burgess, Stephen
    Freitag, Daniel F.
    Pennells, Lisa
    Peters, Sanne A.
    Hart, Carole L.
    Haheim, Lise Lund
    Gillum, Richard F.
    Nordestgaard, Borge G.
    Psaty, Bruce M.
    Yeap, Bu B.
    Knuiman, Matthew W.
    Nietert, Paul J.
    Kauhanen, Jussi
    Salonen, Jukka T.
    Kuller, Lewis H.
    Simons, Leon A.
    van der Schouw, Yvonne T.
    Barrett-Connor, Elizabeth
    Selmer, Randi
    Crespo, Carlos J.
    Rodriguez, Beatriz
    Verschuren, W. M. Monique
    Salomaa, Veikko
    Svardsudd, Kurt
    van der Harst, Pim
    Bjorkelund, Cecilia
    Wilhelmsen, Lars
    Wallace, Robert B.
    Brenner, Hermann
    Amouyel, Philippe
    Barr, Elizabeth L. M.
    Iso, Hiroyasu
    Onat, Altan
    Trevisan, Maurizio
    D'Agostino, Ralph B., Sr.
    Cooper, Cyrus
    Kavousi, Maryam
    Welin, Lennart
    Roussel, Ronan
    Hu, Frank B.
    Sato, Shinichi
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (01): : 52 - 60
  • [9] Positive association of triglyceride-glucose index with new-onset hypertension among adults: a national cohort study in China
    Gao, Qi
    Lin, Yuxin
    Xu, Ruqi
    Luo, Fan
    Chen, Ruixuan
    Li, Pingping
    Zhang, Yuping
    Liu, Jiao
    Deng, Zhenan
    Li, Yanqin
    Su, Licong
    Nie, Sheng
    [J]. CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [10] Measuring and estimating insulin resistance in clinical and research settings
    Gastaldelli, Amalia
    [J]. OBESITY, 2022, 30 (08) : 1549 - 1563